Scientists use CRISPR for first time to correct clotting in newborn and adult mice
CRISPR/Cas9, a powerful genome editing tool, is showing promise for efficient correction of disease-causing mutations. For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania ...
Nov 30, 2016
0
39